Literature DB >> 3006942

Rapid electrophoretic determination of neuron-specific enolase isoenzymes in serum.

J L Viallard, M R Ven Murthy, B Dastugue.   

Abstract

This assay procedure for each of the two neuron-specific enolases (alpha gamma and gamma gamma) and the non-neuronal enolase (alpha alpha) in serum involves two steps: electrophoretic separation of the three isoenzymes--alpha alpha, alpha gamma, and gamma gamma--on cellulose acetate, and bioluminescence measurement of total enolase activity. From these data, the activity concentrations (U/L) of the three isoenzymes in serum are calculated. Both measurement steps are based on the enzymatic activity of enolase and thus differ from the immunological methods currently in use, which require the availability of specific antibodies. The method is rapid (approximately 30 min for both steps) and requires only 10 microL of serum for the complete analysis. Studies of normal children and adults, and of patients suffering from neuroblastoma and small-cell lung cancer, show that it is suitable for clinical use. Furthermore, the fact that both neuron-specific isoenzymes of enolase can be systematically separated is an advantage over immunological techniques in determining isoenzyme patterns for pathological samples.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3006942

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  3 in total

1.  Preparation and purification of gamma gamma enolase (neuron-specific enolase) using high performance anion exchange chromatography.

Authors:  J L Viallard; M R Ven Murthy; B Dastugue
Journal:  Neurochem Res       Date:  1988-01       Impact factor: 3.996

2.  Electrophoretic assessment of aqueous and serum neurone-specific enolase in retinoblastoma and ocular malignant melanoma.

Authors:  B S Shine; J Hungerford; B Vaghela; G A Sheraidah
Journal:  Br J Ophthalmol       Date:  1990-07       Impact factor: 4.638

3.  Multifunctional neuron-specific enolase: its role in lung diseases.

Authors:  Cai-Ming Xu; Ya-Lan Luo; Shuai Li; Zhao-Xia Li; Liu Jiang; Gui-Xin Zhang; Lawrence Owusu; Hai-Long Chen
Journal:  Biosci Rep       Date:  2019-11-29       Impact factor: 3.840

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.